Form 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

Current Report

 

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 28, 2004

 

 

SYNBIOTICS CORPORATION

(Exact name of registrant as specified in its charter)

 

 

Commission file number 0-11303

 

California   95-3737816

(State or other jurisdiction

of incorporation )

  

(I.R.S. Employer

Identification No.)

11011 Via Frontera

San Diego, California

   92127
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (858) 451-3771

 

Item 12. Disclosure of Results of Operations and Financial Condition

 

On May 28, 2004, we issued a press release disclosing our results of operations and financial condition for the year ended December 31, 2003 and the quarter ended March 31, 2004. The press release is furnished as Exhibit 99.1, and is incorporated by reference into this Item 12.

 

-1-

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    SYNBIOTICS CORPORATION

Date: June 2, 2004

  

/s/ Keith A. Butler

   

Keith A. Butler

   

Vice President - Finance and Chief Financial Officer

 

-2-

SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, D.C.

 

EXHIBITS

 

TO

 

FORM 8-K

 

UNDER

 

SECURITIES EXCHANGE ACT OF 1934

 

SYNBIOTICS CORPORATION

EXHIBIT INDEX

 

Exhibit No.
  

Exhibit

99.1  

Press release dated May 28, 2004, entitled “Synbiotics Corporation Reports Year-End and First Quarter Results”.